AI in the pharma R&D world isn’t just about designing better drugs against known drug targets, according to Aitia CEO Colin Hill. Mr Hill discusses how powerful AI can be in understanding novel human causal biology, creating novel drugs, and enhancing patient selection in clinical trials.